Comparison of diagnostic performance between Oncomine Dx target test and AmoyDx panel for detecting actionable mutations in lung cancer

Abstract Companion diagnostic (CDx) tests play important roles in identifying oncogenic driver genes and tailoring effective molecularly targeted therapies for lung cancer patients. In Japan, the Oncomine Dx target test (ODxTT) and the AmoyDx pan lung cancer PCR panel (AmoyDx) are prominent CDx test...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Yuki Nagakubo, Yosuke Hirotsu, Mona Yoshino, Kenji Amemiya, Ryota Saito, Yumiko Kakizaki, Toshiharu Tsutsui, Yoshihiro Miyashita, Taichiro Goto, Masao Omata
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-05-01
Subjects:	Lung cancer Diagnostic Oncomine Amoy False positive
Online Access:	https://doi.org/10.1038/s41598-024-62857-8